These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Is there an association between advanced stage of renal cell carcinoma and paraneoplastic syndrome? Ding GX; Song NH; Feng CC; Xia GW; Jiang HW; Hua LX; Ding Q Med Princ Pract; 2012; 21(4):370-4. PubMed ID: 22237047 [TBL] [Abstract][Full Text] [Related]
5. Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma. Hegemann M; Kroeger N; Stenzl A; Bedke J World J Urol; 2018 Jun; 36(6):849-854. PubMed ID: 29429069 [TBL] [Abstract][Full Text] [Related]
6. Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consortium for Renal Cancer (INMARC). Cotta BH; Meagher MF; Patil D; Saito K; Patel SH; Patel DN; Miller N; Dutt R; Keiner C; Bradshaw AW; Wan F; Eldefrawy A; Yasuda Y; Fujii Y; Master V; Derweesh IH BJU Int; 2021 Mar; 127(3):311-317. PubMed ID: 32772468 [TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information system. Sun R; Breau RH; Mallick R; Tanguay S; Pouliot F; Kapoor A; Lavallée LT; Finelli A; So AI; Rendon RA; Fairey AS; Lattouf JB; Kawakami J; Bhindi B; Basappa NS; Wood LA; Bjarnason GA; Heng DYC; Bansal RK Can Urol Assoc J; 2021 Apr; 15(4):132-137. PubMed ID: 33007184 [TBL] [Abstract][Full Text] [Related]
8. [Clinical features of urological malignancies with paraneoplastic syndromes]. Yang Y; Mao QZ; Li HZ; Rong S; Yan WG; Ji ZG; Liu GH; Xu WF; Xiao H; Wang HJ Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3411-4. PubMed ID: 21223815 [TBL] [Abstract][Full Text] [Related]
9. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy. Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350 [TBL] [Abstract][Full Text] [Related]
10. Acute myocardial infarction and arterial embolism in a patient with newly diagnosed renal mass: management dilemmas! A case report. Martin B; Greinacher A; Bülow R; Hammer F; Hoene A; Burchardt M; Zimmermann U BMC Urol; 2021 Aug; 21(1):111. PubMed ID: 34407783 [TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review. Villagrán-García M; Muñiz-Castrillo S; Ciano-Petersen NL; Vogrig A; Farina A; Villard M; Psimaras D; Alentorn A; Gonçalves D; Fabien N; Rogemond V; Joubert B; Honnorat J J Neurol; 2023 Jan; 270(1):283-299. PubMed ID: 36050418 [TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic signs and symptoms of renal cell carcinoma: implications for prognosis. Kim HL; Belldegrun AS; Freitas DG; Bui MH; Han KR; Dorey FJ; Figlin RA J Urol; 2003 Nov; 170(5):1742-6. PubMed ID: 14532767 [TBL] [Abstract][Full Text] [Related]
13. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy. Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938 [TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic symptoms: cachexia, polycythemia, and hypercalcemia are, respectively, related to vascular endothelial growth factor (VEGF) expression in renal clear cell carcinoma. Ding GX; Feng CC; Song NH; Fang ZJ; Xia GW; Jiang HW; Hua LX; Ding Q Urol Oncol; 2013 Nov; 31(8):1820-5. PubMed ID: 22534085 [TBL] [Abstract][Full Text] [Related]
15. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma. Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of preoperative thrombocytosis in patients who underwent radical nephrectomy for nonmetastatic renal cell carcinoma. Choi JY; Ko YH; Song PH Investig Clin Urol; 2016 Sep; 57(5):324-9. PubMed ID: 27617313 [TBL] [Abstract][Full Text] [Related]
17. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study. Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433 [TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis associated with renal cell carcinoma: a paraneoplastic syndrome or just a coincidence. Zheng Y; Luo J; Jin H; Liu R; Hao H; Gao F BMC Neurol; 2021 Jul; 21(1):277. PubMed ID: 34253185 [TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic elevation of serum alkaline phosphatase in renal cell carcinoma: incidence and implication on prognosis. Chuang YC; Lin AT; Chen KK; Chang YH; Chen MT; Chang LS J Urol; 1997 Nov; 158(5):1684-7. PubMed ID: 9334578 [TBL] [Abstract][Full Text] [Related]
20. Impact of comorbidity on complications after nephrectomy: use of the Clavien Classification of Surgical Complications. Hennus PM; Kroeze SG; Bosch JL; Jans JJ BJU Int; 2012 Sep; 110(5):682-7. PubMed ID: 22432906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]